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Analgesic and anti-inflammatory activities of an aqueous extract produced from Fadogia 
agrestis (family Rubiaceae) stem bark were investigated using animal models. Significant 
dose-dependent increases in the reaction time in the tail-flick test and inhibition of writhing in 
the visceral pain test (i.p. injections of acetic acid) with P up to < 0.001, when compared with 
the control, were observed. In an anti-inflammatory investigation, we also found significant 
dose-dependent inhibitions in the carrageenan-induced paw edema and cotton-pellet 
granuloma tests. The extract in the highest non-sedative dose tested (200 mg/kg) demonstrated 
a potency comparable with that of a reference analgesic anti-inflammatory drug, acetyl 
salicylate (Aspirin, 100 mg/kg). Phytochemical screening revealed the presence of alkaloids 
and saponins in the extract. The relieving effects of Fadogia are probably mediated by the 
influences of active components of the extract on both central and peripheral nociceptive/
antinociceptive neural mechanisms. Therefore, our investigation explains the rationale behind 
the ethnomedicinal usage of the mentioned plant to relieve pain and inflammation, as claimed 
by local users, and shows that further studies of the mechanisms underlying the effects of the 
remedy tested are expedient. 
Keywords: Fadogia agrestis (Schweinf. ex Hiern), analgesic and anti-inflammatory 
effects, tail-flick test, writhing, edema, granuloma.
1 Faculty of Basic Medical Sciences, Ladoke Akintola University of 
Technology, Ogbomoso, Nigeria. 
2 University of Benin, Benin, Nigeria.
Correspondence should be addressed to O. K. Okojie 
(e-mail: pintos4live@yahoo.com).
INTRODUCTION
The quest for natural remedies has been on an increase 
in the 21st century due to availability and affordability 
challenges associated with a number of orthodox 
remedies and also because of insufficient efficacy 
and the existence of significant side effects typical 
of many “standard” drugs. Pain and inflammation are 
common ailments to which remedies are being sought 
on everyday basis. Inflammation, a major causative 
agent of human morbidity and mortality, such as the 
systemic inflammatory response syndrome (SIRS) 
and multiple organ dysfunction syndrome (MODS) 
[1], is prevalent in many localities in the developing 
countries as a result of inadequate health care and a 
low level of health education. In response to these 
challenges, many people “turn to nature.” One of the 
local remedies sought in many African localities is the 
stem bark of Fadogia agrestis (family Rubiaceae), a 
shrub widely distributed in the forest coast of West 
Africa. This plant was reported to be effective for 
wound healing and against diarrhea. Certain effects 
of the plant with respect to the sexual sphere were 
also claimed [2, 3] and proven in a scientific research. 
Since no literature is currently available to substantiate 
possible analgesic and anti-inflammatory properties 
of preparations obtained from the above plant, our 
study was aimed at experimental testing the respective 
properties of this plant as claimed by local users.
METHODS
Plant materials. The plant materials were collected 
in Gambari, a suburb of Ogbomoso city in South 
Western Nigeria, in February, 2009. The plant was 
identified as Fadogia agrestis (Schveinf. ex Hiern) 
and authenticated at the Forestry Research Institute 
of Nigeria (FRIN), Ibadan. A voucher specimen was 
deposited at the Institute.
Extract preparation. The stem bark of Fadogia 
agrestis was dried at 40°C to a constant weight and 
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reduced to a coarse powder with the aid of a laboratory 
grinder. An aqueous extract of the plant was obtained 
by decoction in distilled water for 48 h at room 
temperature. The obtained extract was filtered and 
concentrated in a steam bath. Phytochemical screening 
of the extract for identification of the constituents 
using a standard protocol was performed [4].
Chemicals. Aspirin and carrageenan were purchased 
from Sigma (Great Britain). All other chemicals were 
of an analytical grade and procured locally. 
Animals. Prepubertal male Wistar rats aged 
about 4 weeks and weighing 70-100 g were used in 
investigating the analgesic activity considering that a 
pain-protection influence provided by testosterone in 
adult rats was found in our earlier study [5]. Adult rats 
weighing 200-250 g were used for examination of the 
anti-inflammatory properties of the extract. All animals 
were kept at 23 ± 2oC and a 12/12 h light/dark cycle 
in the preclinical animal house of the Ladoke Akintola 
University of Technology, Ogbomoso (Nigeria). The 
animals were fed with standard rat pellet food and 
provided with water ad libitum; they were acclimatized 
for at least one week before the experimental sessions 
in the laboratory. All the experimental procedures 
were done following the experimental guidelines of 
the Institutional Animal Ethics Committee (IAEC).
Each experimental procedure was applied to 5 
animal groups with 5 rats in each group. Group 1 
served as the control; groups 2-4 (treatment groups) 
were subjected to the actions of the Fadogia extract. 
All the doses mentioned below (50, 100, or 200 mg/kg) 
are indicated for a dry residue of the extract. Group 5 
(reference group) was treated with Aspirin (100 mg/kg). 
Both Aspirin and the extract were administered 
perorally using an oral cannula.
Tail immersion (tail-flick) test. The standard 
procedure was used. Each animal for this procedure was 
held in a suitable soft restrainer with the tail extending 
out. The tail was up to 5 cm dipped into a beaker with 
hot water maintained at 55 ± 0.1oC [6]. The time taken 
for the rat to withdraw the tail (sec) was considered 
the reaction time. Testings in groups 2-5 were carried 
out 30, 60, and 120 min after administration of the 
studied extract or Aspirin.
Acetic acid-induced writhing test. Thirty minutes 
after administrations of the tested extract or Aspirin, 
1% solution of acetic acid was i.p. injected into each 
rat at a dose of 1 mg/100 g body mass [7]. The number 
of writhing motor phenomena, such as contortions 
and stretching, were counted within a 15-min-long 
test interval. The normalized intensity of inhibition 
of writhings was calculated, expressed as percentage, 
and compared with the controls using the relation 
(Nc – Nt)/Nc · 100%, where Nc and Nt are mean 
numbers of writhings in the control (group 1) and test 
groups 2-5, respectively.
Carrageenan-induced paw edema test. Acute 
inflammation was produced in the hindlimb by injection 
of 1% solution of carrageenan (0.1 ml/100 g body mass) 
into the plantar surface of the hind paw [8] 30 min 
after administrations of the extract or Aspirin. The paw 
edema was measured at the intervals of 1, 2, 3, and 
4 h using a plethysmometer. The normalized intensity 
of suppression of paw edema among different animal 
groups was compared using the formula analogous to 
that mentioned above: (Vc – Vt)/Nc · 100%, where Vc 
and Vt are mean increases in the paw volume in the 
control and test groups, respectively.
Cotton pellet granuloma test. Rats were anesthetized 
by i.p. ketamine injections, and 2-cm-long incision 
was made on the rats’ groin region. An autoclaved 
cotton pellet weighing 50 mg was implanted in this 
region of each rat [9]. All the animals in each group 
were dosed once for 7 days. On the 8th day, animals 
were sacrificed by cervical dislocation, and the cotton 
pellet along with the granuloma tissue was extracted 
and dried in an oven at 55oC for 24 h. The resulting 
cotton pellet weights were compared with the control, 
and the normalized intensity of inhibition of the 
development of granuloma by the tested remedies was 
calculated.
The numerical data are represented as means ± 
± s.e.m.; Student’s t-test was performed, and P < 0.05 
values were considered as confirming a significant 
intergroup difference.
RESULTS
Introduction of the extract of Fadogia agrestis bark 
to experimental rats led to significant suppression of 
the tail-flick reflex induced by noxious stimulation 
of thermonociceptors in the tail skin. The effect 
demonstrated a clear dose dependence. When 50 or 100 
mg of the extract dry residue per 1 kg of the body mass 
were introduced, the delay of the tail flick movement 
showed twofold to threefold increases or more, as 
compared with the mean delay in the control group 1. 
When the highest tested dose (200 mg/kg, group 4) was 
used, the tail flick delay reached 490-577% of that in the 
control group. Thus, the analgesic effect of the extract 
introduced in a dose of 200 mg/kg was weaker than 
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that of 100 mg/kg Aspirin (the latter latency increase in 
the test used was eight- to ninefold or more) but quite 
comparable with the effect of the above-mentioned 
well-known and extensively used (“classic”) anti-
nociceptive and anti-inflammatory drug. The effects of 
the extract were rather stable within the observation 
period (2 h) and even became somewhat more intense 
within this time interval (Fig. 1A-C).
In the test where visceral pain was induced (i.p. 
injection of acetic acid solution), the Fadogia extract 
also demonstrated significant analgesic effects. Thirty 
minutes after extract administration, introductions of 
all the three doses used resulted in decreases in the 
number of writhing motor effects observed within a 
15-min-long observation interval. The antinociceptive 
effect was relatively mild (a 12.6% decrease) at the 
lowest dose (50 mg/kg) used; but in the case where 
200 mg/kg of the extract dry residue were introduced, 
the number of writhings dropped more than two times. 
For comparison, 100 mg/kg Aspirin caused an about 
threefold decrease in the number of writhings (Fig. 2).
In control rats, injection of carrageenan (0.2 ml of 1% 
solution per 100 g of the body mass) into the hindpaw 
plantar surface resulted in the development of edema in 
the injured limb. One hour after carrageenan injection, 
the edema volume was, on average, 1.81 ± 0.01 ml, 
and the volume increased to 1.94 ± 0.01 ml (a 7.2% 
rise, P < 0.05) on the 4th h. The Fadogia extract in the 
50 mg/kg dose decreased the edema volume within this 
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Fig. 1. Analgesic activity of the extract of Fadogia agrestis in 
the tail-flick test. Diagrams of the mean delays (sec) of tail-flick 
movements (±s.e.m.) observed in different groups of animals 
(5 rats each) 30, 60, and 120 min (shown at the right, A-C) after 
introductions of 50, 100, and 200 mg/kg of the extract (groups 2-4, 
respectively) and of 100 mg/kg Aspirin (group 5). The data for the 
control group 1 are also shown. Two and three asterisks show cases 
of significant differences with P < 0.01 and P < 0.001 from the 
values in the control group 1. 
Р и с. 1. Знеболювальна активність екстракту Fadogia agrestis у 
тесті відсмикування хвоста.
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Fig. 2. Analgesic activity of the Fadogia extract in the acetic acid-
induced writhing test. Diagrams of the mean numbers of writhings 
within a 15-min-long observation period 30 min after introduction 
of the remedies tested. One asterisk shows significant difference 
with P < 0.05 from the values in group 1. Other designations are 
similar to those in Fig. 1.
Р и с. 2. Знеболювальна активність екстракту Fadogia agrestis у 
тесті корчів, викликаних уведенням оцтової кислоти.
***
***
***
*
ANALGESIC AND ANTI-INFLAMMATORY EFFECTS
НЕЙРОФИЗИОЛОГИЯ / NEUROPHYSIOLOGY.—2010.—T. 42, № 2150
period by 5.5 to 16.0%, while the respective decrease 
at the 200 mg/kg dose varied from 42.0 to 62.4%. The 
latter effect was again quite comparable with a positive 
effect of Aspirin in the dose used, namely from 61.3 to 
71.1% (Fig. 3A-D).
These results agreed well with the results of the 
cotton pellet granuloma test. At the extract dry residue 
doses 50, 100, and 200 mg/kg, the normalized masses 
of the pellet, as compared with the corresponding 
index in the control group 1, were smaller by 16.5, 
46.3, and 78.9%, respectively. Administration of 
Aspirin provided a 87.1% decrease in the pellet mass; 
so, the anti-inflammatory efficacy of the extract in the 
highest dose used was again quite comparable with 
that of Aspirin in a rather high dosage. 
DISCUSSION
The results of our study showed that the aqueous extract 
of Fadogia agrestis (Schweinf. ex Hiern) stem bark 
induces considerable dose-dependent analgesic effects 
against the writhing syndrome observed in the acetic 
acid test. These abdominal writhes, which result from 
the action of severe visceral pain [10], are probably 
suppressed mostly by a peripheral analgesic effect 
of the remedies tested [11–13]. In peripheral tissues, 
the development of pain is mostly a consequence 
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Fig. 3. Anti-inflammatory activity of the Fadogia extract in the 
carrageenan-induced paw edema test. Diagrams of mean increases 
in the paw volume (ml) resulting from edema 1, 2, 3, and 4 h after 
carrageenan injection (A-D, respectively). Designations are similar 
to those in Figs. 1 and 2.
Р и с. 3. Протизапальна активність екстракту Fadogia agrestis у 
тесті набряку лапи, індукованого введенням карагеніну.
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Fig. 4. Anti-inflammatory activity of the Fadogia extract in the 
cotton pellet granuloma test. Diagrams of normalized mean weights 
of the pellet (%; weight in the control group 1 is taken as 100%). 
Other designations are similar to those in Fig. 1-3. 
Р и с. 4. Протизапальна активність екстракту Fadogia agrestis у 
тесті гранульоми, індукованої імплантацією ватного тампона.
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of sensitization of the chemosensitive nociceptors 
by prostaglandins [14]. The result obtained in this 
model, therefore, suggests that the pain-suppressing 
effect of the extract may be due to inhibition of 
prostaglandin synthesis. However, our suggestion on 
an analgesic effect of the extract was not based on 
this model alone, because several compounds, such as 
tricyclic antidepressants [15] and histamine [16], also 
exhibit suppression of the writhing syndrome. A more 
specific model (tail immersion test) based on noxious 
stimulation of thermonociceptors was employed 
to investigate the analgesic potential of the extract 
against this type of pain. The result showed clear dose-
dependent increases in the reaction time in the above 
test. This model provides an evidence that the extract 
exerts not only peripheral effects on nociceptors but 
probably possesses some central action on the spinal 
and cerebral antinociception neuronal systems [17].
We also investigated the anti-inflammatory 
potential of the extract. Inflammatory events 
involve microvascular changes with increased 
vascular permeability, flow of exudation (including 
plasmatic proteins), and increase in the amounts 
of endogenous mediators [18]. Non-steroidal anti-
inflammatory drugs (NSAIDs) are common means 
against superficial nociception and inflammation. 
NSAIDs alleviate hyperalgesic symptoms associated 
with inflammation by inhibiting the cyclooxygenase 
activity and by resultant inhibition of prostaglandin 
synthesis from arachidonic acid [19]. Our results 
demonstrated intense dose-dependent inhibitions of 
paw edema (in the carrageenan-induced paw edema 
model) and the development of granuloma (in cotton 
pellet granuloma model). The maximum nonsedative 
dose offered the highest level of protection in both 
models of inflammation, probably mostly by inhibiting 
prostaglandin synthesis.
As was mentioned above, the Fadogia extract 
exerted analgesic and anti-inflammatory effects 
quite comparable in their intensity with the effects 
of the “standard” NSAID Aspirin, one of the most 
extensively used remedies. It should be taken into 
account that we used in our tests a rather high dose of 
this drug (which is much higher than the doses usually 
introduced in clinics) to provide the most demonstrative 
antinociceptive and anti-inflammatory effect in the 
reference animal group. Naturally, the Fadogia extract 
can demonstrate even stronger analgesic effects, as 
compared with those of smaller Aspirin doses.
Phytochemical screening results confirmed that 
significant amounts of alkaloids and saponins, the 
constituents which have been reported in other 
members of the botanical family Rubiaceae and 
identified as potent analgesics, are present in the 
Fadogia extract; much lesser amounts of flavonoids 
and antraquinone were also found  [20, 21]. These 
constituents could be responsible for analgesic and 
anti-inflammatory potentials of the studied extract. We 
hereby suggest that further studies on characterization 
and identification of the molecular structure of different 
constituents present in the extract and the possibilities 
for its applicability in medicinal chemistry and for the 
development of novel remedies are rather expedient. 
Of course, this also presupposes the necessity of 
technological perfection of preparation of clinically 
usable drugs from plant raw materials and detailed 
clinical testing of such remedies. 
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Р е з ю м е
Знеболювальна й протизапальна активність водного 
екстракту, виготовленого з кори Fadogia agrestis (сімейство 
Маренові), вивчалася на щурах з використанням різних 
моделей болю та запалення. Екстракт забезпечував 
дозозалежне збільшення часу реакції в тесті відсмикування 
хвоста та посилення гальмування корчів у тесті вісцерального 
болю (індукованого внутрішньоочеревинними ін’єкціями 
оцтової кислоти) з Р аж до <0.001 порівняно з контролем. 
Вивчаючи протизапальні ефекти екстракту Fadogia, ми 
також виявили значне дозозалежне пригнічення запалення 
в тестах набряку лапи, індукованого введенням карагеніну, 
та розвитку гранульоми, індукованого імплантацією 
ватного тампона. Цей екстракт, застосований у найвищій 
неседативній дозі (200 мг/кг), демонстрував ефективність, 
цілком порівняну з такою еталонного знеболюючого і 
протизапального агента – ацетилсаліцилата (аспірину, 
100 мг/кг). Фітохімічний скринінг дозволив нам виявити в 
екстракті присутність алкалоїдів, сапонінів та флавоноїдів. 
Знеболювальні ефекти Fadogia опосередковуються, 
вірогідно, впливами активних компонентів екстракту як 
на центральні, так і на периферичні нервові ноцицептивні/
антиноцицептивні механізми. Отже, результати наших 
досліджень логічно обгрунтовують ефекти використання 
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згадуваної рослини в етнічній медицині з метою ослаблення 
болю й пригнічення запалення, а також свідчать про 
доцільність подальшого вивчення механізмів, що лежать в 
основі дії тестованого лікувального засобу.
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